![Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-022-01845-z/MediaObjects/41416_2022_1845_Fig4_HTML.png)
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
![Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy | Anticancer Research Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/5/2583/F1.large.jpg)
Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy | Anticancer Research
![Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-022-01845-z/MediaObjects/41416_2022_1845_Fig2_HTML.png)
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
![Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum](https://discourse.datamethods.org/uploads/default/original/2X/7/75bb0160b856873819cdcefe4dc6072ed7ef267c.png)
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum
![Early Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with Early Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with](https://mma.prnewswire.com/media/584686/Overall_Survival_Pancreas_Graph_Infographic.jpg?w=200)
Early Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with
![Kaplan Meier Mistakes. Kaplan Meier analysis is often misused… | by Tomas Bencomo | Towards Data Science Kaplan Meier Mistakes. Kaplan Meier analysis is often misused… | by Tomas Bencomo | Towards Data Science](https://miro.medium.com/v2/resize:fit:1400/1*YB4vrBR4vo0BgZ-MEGypNw.png)
Kaplan Meier Mistakes. Kaplan Meier analysis is often misused… | by Tomas Bencomo | Towards Data Science
![Predicting Mean Survival Time from Reported Median Survival Time for Cancer Patients - Mette L. Lousdal, Ivar Sønbø Kristiansen, Bjørn Møller, Henrik Støvring, 2017 Predicting Mean Survival Time from Reported Median Survival Time for Cancer Patients - Mette L. Lousdal, Ivar Sønbø Kristiansen, Bjørn Møller, Henrik Støvring, 2017](https://journals.sagepub.com/cms/10.1177/0272989X16655341/asset/images/large/10.1177_0272989x16655341-fig3.jpeg)
Predicting Mean Survival Time from Reported Median Survival Time for Cancer Patients - Mette L. Lousdal, Ivar Sønbø Kristiansen, Bjørn Møller, Henrik Støvring, 2017
![Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of](https://ars.els-cdn.com/content/image/1-s2.0-S0959804914008727-gr1.jpg)
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
![Meta-analysis when only the median survival times are known: A comparison with individual patient data results | International Journal of Technology Assessment in Health Care | Cambridge Core Meta-analysis when only the median survival times are known: A comparison with individual patient data results | International Journal of Technology Assessment in Health Care | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20170224050738-52874-mediumThumb-S0266462305050154fig001g.jpg?pub-status=live)
Meta-analysis when only the median survival times are known: A comparison with individual patient data results | International Journal of Technology Assessment in Health Care | Cambridge Core
![Survival curves. (A) Overall survival (median 18.2 months). (B) PS of... | Download Scientific Diagram Survival curves. (A) Overall survival (median 18.2 months). (B) PS of... | Download Scientific Diagram](https://www.researchgate.net/publication/44901947/figure/fig1/AS:601654286118955@1520456968641/Survival-curves-A-Overall-survival-median-182-months-B-PS-of-zero-versus-one-or.png)
Survival curves. (A) Overall survival (median 18.2 months). (B) PS of... | Download Scientific Diagram
![Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram](https://www.researchgate.net/publication/5872888/figure/fig1/AS:601697068015627@1520467168720/Overall-survival-curve-Median-overall-survival-time-was-82-months-The-initial-date-of.png)
Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram
![Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018) | BMC Cancer | Full Text Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018) | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-021-09078-8/MediaObjects/12885_2021_9078_Fig1_HTML.png)